Predictions
Cidara Therapeutics Inc
Start price
Target price
Perf. (%)
€1.83
13.04.21
13.04.21
-
13.04.22
13.04.22
-60.43%
14.04.22
14.04.22
Revenue growth >5% per year expected
Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€21.16
28.03.22
28.03.22
-
28.03.23
28.03.23
-9.86%
02.04.22
02.04.22
Risky Investment
Lipocine Inc.
Start price
Target price
Perf. (%)
€28.44
29.03.22
29.03.22
-
29.03.23
29.03.23
-28.90%
02.04.22
02.04.22
Risky Investment
Lipocine Inc.
Start price
Target price
Perf. (%)
€25.25
21.03.22
21.03.22
€0.000
21.03.23
21.03.23
-19.90%
02.04.22
02.04.22
Below average Management
high free float
High risks for its business
Unknown brand
PAVmed Inc
Start price
Target price
Perf. (%)
€1.35
21.03.22
21.03.22
€8.00
21.03.23
21.03.23
-14.92%
02.04.22
02.04.22
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Revenue decline/stagnation expected
Kineta Inc.
Start price
Target price
Perf. (%)
€12.46
24.03.22
24.03.22
-
24.03.23
24.03.23
-23.03%
02.04.22
02.04.22
Probably not worthwhile Investment
Vyant Bio Inc.
Start price
Target price
Perf. (%)
€8.50
30.03.22
30.03.22
-
30.03.23
30.03.23
-24.12%
31.03.22
31.03.22
Risky Investment
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€13.20
06.03.22
06.03.22
-
06.03.23
06.03.23
17.35%
17.03.22
17.03.22
Risky Investment
Eurobio scientific
Start price
Target price
Perf. (%)
€28.54
26.12.21
26.12.21
-
26.12.22
26.12.22
-32.45%
14.03.22
14.03.22
Could be worthwhile Investment >10% per year
Vivoryon Therapeutics N.V.
Start price
Target price
Perf. (%)
€19.50
06.01.22
06.01.22
-
06.01.23
06.01.23
-45.13%
13.03.22
13.03.22
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€36.19
07.03.21
07.03.21
-
07.03.22
07.03.22
-62.14%
08.03.22
08.03.22
EBIT growth >5% per year expected
Capable Management
Could be worthwhile Investment >10% per year
Little innovation
Sierra Oncology Inc.
Start price
Target price
Perf. (%)
€28.40
24.02.22
24.02.22
€50.00
24.02.23
24.02.23
-4.93%
07.03.22
07.03.22
Could be very worthwhile Investment >20% year
X T L Biopharmaceuticals Ltd ADR
Start price
Target price
Perf. (%)
€2.80
06.03.21
06.03.21
-
06.03.22
06.03.22
-25.00%
07.03.22
07.03.22
Could be very worthwhile Investment >20% year
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€8.98
21.02.21
21.02.21
€10.00
21.02.22
21.02.22
-54.90%
22.02.22
22.02.22
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Known brand
Very Future proof/growth oriented business model
Seelos Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.88
07.02.21
07.02.21
€5.00
07.02.22
07.02.22
-66.49%
08.02.22
08.02.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€12.78
24.01.22
24.01.22
-
24.01.23
24.01.23
22.85%
07.02.22
07.02.22
Could be worthwhile Investment >10% per year
Very high cyclical dependencies
BiondVax Pharmaceuticals Ltd ADR
Start price
Target price
Perf. (%)
€0.40
04.02.22
04.02.22
-
-
06.02.22
06.02.22
Risky Investment
Sierra Oncology Inc.
Start price
Target price
Perf. (%)
€19.20
25.01.22
25.01.22
€27.00
25.01.23
25.01.23
39.58%
05.02.22
05.02.22
Could be worthwhile Investment >10% per year
Capable Management
Good culture
Few uniques
Theranexus
Start price
Target price
Perf. (%)
€9.02
11.09.21
11.09.21
€10.00
11.09.22
11.09.22
-64.80%
04.02.22
04.02.22
Could be worthwhile Investment >10% per year
Visiomed Group
Start price
Target price
Perf. (%)
€0.86
25.01.21
25.01.21
€1.00
25.01.22
25.01.22
-80.01%
24.01.22
24.01.22
Could be worthwhile Investment >10% per year
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€23.62
15.10.21
15.10.21
-
18.01.25
18.01.25
-45.89%
24.01.22
24.01.22
Could be worthwhile Investment >10% per year
Very high cyclical dependencies
Atossa Genetics Inc
Start price
Target price
Perf. (%)
€1.85
23.01.21
23.01.21
€60.00
23.01.22
23.01.22
-41.51%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year